Awad M, Ruzza A, Soliman C, Pinzás J, Marban E, Trento A, Czer L S C
Division of Cardiology, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Division of Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Transplant Proc. 2014 Dec;46(10):3580-4. doi: 10.1016/j.transproceed.2014.05.084.
Orthotopic heart transplantation (OHT) is performed using the bicaval and pulmonary venous anastomoses or the standard (biatrial) anastomoses. The special considerations of endomyocardial biopsy after OHT using the bicaval technique, and after myocardial infarction for harvesting of cardiac stem cells, have not been described.
When approached via the right or left internal jugular vein, important technical considerations were ultrasound guidance for vascular access; a soft, 80-cm, 0.035-inch, J-tipped guidewire; a long (23-cm), 7-Fr sheath; and a flexible 7-Fr, 50-cm bioptome. These technical aspects were helpful to avoid disruption of the superior vena cava suture line, avoid entry into the right atrial appendage or coronary sinus, avoid right ventricular free wall perforation, and provide ready access to the right ventricular septal wall. We used the same principles and technical considerations when obtaining the cardiac stem cells after myocardial infarction in patients enrolled in the CADUCEUS trial.
From January 2002 to December 2005, 754 biopsy procedures were performed in 179 patients after OHT with the bicaval technique, using bioptome A. There was 1 occurrence of ventricular fibrillation requiring cardioversion, and no occurrence of cardiac tamponade during the procedure. From January 2006 to September 2013, 2818 biopsy procedures were performed in 1064 patients using bioptome B. No patient developed ventricular fibrillation or cardiac tamponade during the procedure. In 2010 and 2011, 23 biopsy procedures were performed in 23 patients after acute myocardial infarction, using bioptome B. No immediate complications occurred while performing these biopsies. The late occurrence of tricuspid regurgitation was not evaluated in this study.
Endomyocardial biopsy procedures can be safely performed after OHT with the bicaval technique and after myocardial infarction for harvesting of cardiac stem cells. Ultrasound guidance for vascular access, a long guidewire and sheath, and a flexible bioptome are important features for the safe conduct of the biopsy procedure.
原位心脏移植(OHT)采用双腔静脉和肺静脉吻合术或标准(双心房)吻合术进行。关于采用双腔静脉技术进行OHT后以及心肌梗死后获取心脏干细胞时心内膜活检的特殊注意事项尚未见报道。
经右或左颈内静脉进行操作时,重要的技术要点包括超声引导血管穿刺;使用一根柔软的、80厘米长、0.035英寸的J形头导丝;一根长(23厘米)的7F鞘管;以及一根可弯曲的7F、50厘米的心内膜活检钳。这些技术方面有助于避免上腔静脉缝线处破裂,避免进入右心耳或冠状窦,避免右心室游离壁穿孔,并便于进入右心室间隔壁。在参加CADUCEUS试验的患者心肌梗死后获取心脏干细胞时,我们采用了相同的原则和技术要点。
2002年1月至2005年12月,179例接受双腔静脉技术OHT后的患者使用活检钳A进行了754次活检操作。术中发生1次需要进行心脏复律的室颤,未发生心脏压塞。2006年1月至2013年9月,1064例患者使用活检钳B进行了2818次活检操作。术中无患者发生室颤或心脏压塞。2010年和2011年,23例急性心肌梗死后的患者使用活检钳B进行了23次活检操作。进行这些活检时未发生即刻并发症。本研究未评估三尖瓣反流的晚期发生情况。
采用双腔静脉技术进行OHT后以及心肌梗死后获取心脏干细胞时,可以安全地进行心内膜活检操作。超声引导血管穿刺、长导丝和鞘管以及可弯曲的心内膜活检钳是安全进行活检操作的重要特征。